Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: A six-month outcome analysis in 103 patients.
Fiche publication
Date publication
décembre 2023
Journal
Diagnostic and interventional imaging
Auteurs
Membres identifiés du Cancéropôle Est :
Pr LOFFROY Romaric
Tous les auteurs :
Loffroy R, Quirantes A, Guillen K, Mazit A, Comby PO, Aho-Glélé LS, Chevallier O
Lien Pubmed
Résumé
The purpose of this study was to assess the feasibility, safety, and 6-month outcomes of prostate artery embolization (PAE) using N-butyl-cyanoacrylate (NBCA) glue as the only embolic agent in patients with benign prostatic hyperplasia (BPH)-related lower urinary tract symptoms.
Mots clés
Benign prostate hyperplasia, Cyanoacrylates, Lower urinary tract symptoms, Outcome studies, Prostate artery embolization
Référence
Diagn Interv Imaging. 2023 12 30;: